Drug intelligence / Profile preview

calf blood-deproteinized extract + sodium hyaluronate

Development stage: Unknown
Modality: Small Molecules
Administration: Intraarticular, Ophthalmic

Overview

A combination drug containing calf blood-deproteinized extract and sodium hyaluronate. The sodium hyaluronate component is similar to a substance that occurs naturally in joints and acts as a lubricant and shock absorber. It is commonly used to treat osteoarthritis of the knee by improving joint lubrication and reducing pain.

Beyond the preview

Go deeper on calf blood-deproteinized extract + sodium hyaluronate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on calf blood-deproteinized extract + sodium hyaluronate.

Explore the full profile